Delivery Order SPE2DB22D1106-SPE2DB25FFHB7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for OxyContin ER 10 mg tablets (100-count units) with a contract value of $1,613.41. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, represents a small-value pharmaceutical supply transaction executed under a competitive, non-set-aside procurement process. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count) valued at $1,908.93, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $2,098.96. This is a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 5, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units) with a contract ceiling value of $1,824.59. This is a firm fixed-price delivery order with an ultimate completion date of May 6, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,458.52, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under the contractor's larger pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of OxyContin ER 10 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $1,955.66, is set to be completed by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside basis, indicating open competitive procurement. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (quantity 100s) with a ceiling value of $1,316.65. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a competitive award with no set-aside designation. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of OxyContin ER 10 mg tablets in quantities of 100 units. This firm fixed price delivery order has a ceiling value of $3,078.96 and an ultimate completion date of September 15, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $2,370.38 delivery order contract on September 18, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). The contract is structured as a firm fixed-price delivery order with a completion date of September 19, 2025, and represents a non-set-aside competitive award. The awardee will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $1,365.32. This non-set-aside, firm fixed-price delivery order was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHB7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $1,766.17. This firm fixed-price, non-set-aside delivery order was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's status as a major pharmaceutical distributor with an extensive federal contract portfolio demonstrates its established capability to fulfill critical medical procurement requirements for Defense Health Agency customers and other federal healthcare systems through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/5/25 |